58.20CHF+2.28%Mkt Cap: 1.15B $P/E: —2d ago
Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-ass…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap1.15B $
Enterprise Value942.04M $
Revenue (TTM)117.20M $
Gross Profit57.70M $
Net Income (TTM)-4.12M $
Revenue/Share7.100 USD
Last Price58.20 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees365
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINNL0011832936
Valuation
P/E (Trailing)—
P/E (Forward)17.31
PEG—
EV/EBITDA685.56
EV/Revenue8.04
P/S9.83
P/B1.88
EPS (TTM)-0.35
EPS (Forward)3.39
52W Range
56.5031% of range62.00
52W High62.00 CHF
52W Low56.50 CHF
Profitability
Gross Margin48.53%
Oper. Margin-17.73%
EBITDA Margin1.17%
Profit Margin-3.46%
ROE-0.75%
ROA-0.59%
Growth
Revenue Growth-2.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.25M $
CapEx (TTM)6.23M $
FCF Margin-26.44%
FCF Yield-2.69%
Net Debt-217.26M $
Net Debt/EBITDA-158.11
Balance Sheet
Debt/Equity0.01
Current Ratio10.66
Quick Ratio9.84
Book Value/Sh31.16 CHF
Cash/Share11.32 CHF
Dividends
Fwd Div Rate1.920 CHF
Trail. Div Rate2.100 CHF
Div. Yield3.27%
5Y Avg Yield—
Payout Ratio113.48%
Ex-Div DateApr 24, 2026
Pay DateJun 6, 2025
Analyst Consensus
Rating—
Target (Mean)123.22 CHF
Upside (mean)+111.7%
Target Range93.09 CHF – 164.08 CHF
CHF93.09+111.7% to meanCHF164.08
# Analysts5
Ownership
Shares Out.17.19M
Float9.69M
Insiders51.77%
Institutions18.94%
Technical
SMA 5064.72 (-10.1%)
SMA 20085.18 (-31.7%)
Beta1.48
S&P 52W Chg20.80%
Avg Vol (30d)26.49K
Avg Vol (10d)22.68K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—